Meeting
2023 ASCO Annual Meeting
The number of lymph nodes examined as a poor prognosis factor in stage II and stage III colon cancer patients undergoing curative surgery.
Authors
JEONGSEOK JEON
Yonsei University College of Medicine, Seoul, South Korea
JEONGSEOK JEON , Lingjie Shen , Yitak Kim , Hyunwook Kim , Anna J. van Gestel , Yoon Dae Han , Dai Hoon Han , Seng Chan You , Joong Ahn , Sangjoon Shin , Gijs Geleijnse , Han Sang Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3612)
DOI
10.1200/JCO.2023.41.16_suppl.3612
Abstract #
3612
Poster Bd #
312
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Prognostic relevance of primary tumor location in stage III and II colon cancer: Experience at University Hospital Ramon y Cajal (HURyC) Madrid.
First Author: Arantzazu Martínez Barquín García
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.
First Author: David Viñal
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Predicting recurrence in patients with stage II and III colon cancer: Validation cohort and long-term follow-up of the experimental cohort.
First Author: David Viñal
Poster
2022 ASCO Annual Meeting
Effect of more versus less frequent abdominopelvic computed tomography follow-up testing on overall survival in patients with stage II or III colon cancer.
First Author: Jeon Jeongseok